Pet Intravenous (IV) Fluid Supplies Market Global Report 2026

The pet intravenous (IV) fluid supplies market size has grown strongly in recent years. It will grow from $1.16 billion in 2025 to $1.25 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to limited availability of sterile veterinary IV consumables in clinical settings, dependence on basic manual fluid therapy practices, low penetration of advanced veterinary critical care infrastructure, reduced pet healthcare expenditure in emerging economies, limited awareness of intensive care treatments for animals.

The pet intravenous (IV) fluid supplies market size is expected to see strong growth in the next few years. It will grow to $1.72 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing adoption of advanced veterinary infusion systems, rising investments in veterinary healthcare infrastructure expansion, growing penetration of pet insurance and structured spending on animal healthcare, expansion of specialty and emergency veterinary care facilities, and increasing focus on precision dosing and animal patient monitoring. Major trends in the forecast period include rising pet ownership and growing humanization of companion animals, increasing prevalence of chronic and age-related diseases in pets, expansion of veterinary emergency and critical care infrastructure, greater awareness of advanced animal healthcare and preventive treatments, and rising demand for cost-effective veterinary treatment and standardized fluid therapy solutions.

The rising pet ownership is expected to drive the growth of the pet intravenous (IV) fluid supplies market going forward. Pet ownership refers to the responsibility of caring for a domesticated animal, such as a dog, cat, bird, or other pets, by fulfilling its basic needs, well-being, and overall welfare throughout its life. Pet ownership is increasing due to rising urbanization, as a growing number of people living in cities seek companionship and emotional support from pets in smaller, often isolated living spaces. Pet ownership supports the demand for pet intravenous (IV) fluid supplies by generating steady demand for veterinary care, encouraging owners to invest in ongoing treatment for conditions such as kidney disease or dehydration in pets, and increasing the availability, stocking, and accessibility of IV fluids in veterinary clinics and pet healthcare services. For instance, according to the 2024 Annual Analysis report published by Shelter Animals Count, a US-based non-profit organization, in 2024, total dog and cat adoptions reached 4,192,443, including 2 million dogs and 2 million cats, reflecting a slight increase of 0.4 percent or 17,153 more adoptions compared to 2023. Therefore, the rising pet ownership is driving the growth of the pet intravenous (IV) fluid supplies market.

The expansion of veterinary services is expected to drive the growth of the pet intravenous (IV) fluid supplies market going forward. Veterinary services refer to the professional medical care and treatment provided to animals, including diagnosis, prevention, and management of diseases, as well as routine health services such as vaccinations and surgeries. Veterinary services are expanding due to the growing number of pet owners, which is driving higher demand for regular animal healthcare, preventive treatments, and specialized medical services. The expansion of veterinary services increases the adoption of pet intravenous (IV) fluid supplies by improving access to advanced treatments, enabling more clinics to offer critical care procedures, and encouraging routine use of IV therapy for managing dehydration and chronic illnesses in pets. For instance, in February 2026, according to the American Veterinary Medical Association, a US-based not-for-profit organization, at the national level, veterinary practices recorded revenue increases of approximately 2.5% in 2025. Therefore, the expansion of veterinary services is driving the growth of the pet intravenous (IV) fluid supplies market.

In June 2023, Mars Incorporated, a US-based pet care and food conglomerate, acquired Heska Corporation for an undisclosed amount. Through this acquisition, Mars, Incorporated intended to reinforce and expand its veterinary diagnostics and pet healthcare capabilities by integrating Heska’s point-of-care testing solutions, laboratory instruments, and diagnostic offerings into its wider Science & Diagnostics division, thereby strengthening end-to-end veterinary care services and accelerating innovation in companion animal health solutions. Heska Corporation is a US-based veterinary diagnostics company that specializes in developing and supplying pet intravenous (IV) fluid products.

Major companies operating in the pet intravenous (IV) fluid supplies market are Zoetis Inc., Baxter International Inc., Fresenius SE & Co. KGaA, B. Braun Melsungen Aktiengesellschaft, Abbott Laboratories, ICU Medical Inc., Covetrus Inc., Henry Schein Inc., Terumo Corporation, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Norbrook Laboratories Limited, Mila International Inc., Jorgensen Laboratories Inc., Moog Inc., Rusoma Laboratories Private Limited, Sykes Veterinary International Limited, Aromor Animal Health Private Limited.

North America was the dominant region in the pet intravenous (IV) fluid supplies market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in pet intravenous (IV) fluid supplies report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pet intravenous (IV) fluid supplies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pet intravenous (IV) fluid supplies market consists of sales of IV fluids, infusion sets, catheters, IV bags, drip chambers, fluid administration sets, needles, cannulas, extension lines, and related consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The pet intravenous (IV) fluid supplies market research report is one of a series of new reports that provides pet intravenous (IV) fluid supplies market statistics, including pet intravenous (IV) fluid supplies industry global market size, regional shares, competitors with a pet intravenous (IV) fluid supplies market share, detailed pet intravenous (IV) fluid supplies market segments, market trends and opportunities, and any further data you may need to thrive in the pet intravenous (IV) fluid supplies industry. This pet intravenous (IV) fluid supplies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.